Company intelligence / Profile preview

InspiRx

Somerset, New Jersey, United States

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Preclinical and early clinical work suggests improved targeted pulmonary delivery of antibiotics and drugs for ventilated and critically ill patients. Results indicate the proprietary technology delivers higher or more efficient dosing than comparators in simulated/adult and pediatric setting

Therapeutic areas: PulmonologyInfectious Diseases
Modalities: DeviceSmall molecule
Industry: Biotech

Partnerships

Research Foundation for SUNY (technology licensing and co-development)

Beyond the preview

Go deeper on InspiRx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on InspiRx.

Explore the full profile